Paradigm Biocapital Advisors LP

CIK

1855655

City

NEW YORK

State / Country

NY

Stock

ACLX — Arcellx, Inc.

Top Portfolio Positions

35 positions · $4,894,261,596 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
ACLX	Arcellx, Inc. Healthcare	5,774,016	$662,972,517	13.55%
RVMD	Revolution Medicines, Inc. Healthcare	6,655,703	$647,267,116	13.23%
NUVL	Nuvalent, Inc. Healthcare	5,324,433	$545,488,160	11.15%
PCVX	Vaxcyte, Inc. Healthcare	4,793,020	$278,522,392	5.69%
EWTX	Edgewise Therapeutics, Inc. Healthcare	7,365,038	$231,998,697	4.74%
GMAB	Genmab A/S Healthcare	7,967,836	$213,777,039	4.37%
INSM	INSMED Inc Healthcare	1,254,488	$205,133,877	4.19%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	2,562,154	$179,735,103	3.67%
BLTE	Belite Bio, Inc Healthcare	1,114,784	$177,741,160	3.63%
ERAS	Erasca, Inc. Healthcare	10,392,702	$168,153,918	3.44%

Portfolio Trend

16 quarters · across all stocks

Holdings in ACLX

Compact Export CSV

Shares Held

Position Value (USD)

14 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$662,972,517	5,774,016	+0.9%	Shares	Sole	2026-05-15
2025-12-31	$373,205,843	5,724,016	+23.1%	Shares	Sole	2026-02-17
2025-06-30	$306,137,703	4,649,016	+3.5%	Shares	Sole	2025-08-14
2025-03-31	$294,677,299	4,492,032	+2.8%	Shares	Sole	2025-05-15
2024-12-31	$335,258,080	4,371,601	+9.3%	Shares	Sole	2025-02-14
2024-09-30	$334,040,000	4,000,000	+400.0%	Shares	Sole	2024-11-14
2024-09-30	$66,808,000	800,000	-79.2%	Call	Sole	2024-11-14
2024-06-30	$212,376,363	3,848,095	+0.8%	Shares	Sole	2024-08-14
2024-03-31	$265,548,507	3,818,095	+4.4%	Shares	Sole	2024-05-15
2023-12-31	$203,053,632	3,658,624	+23.9%	Shares	Sole	2024-02-14
2023-09-30	$105,958,017	2,953,122	+25.8%	Shares	Sole	2023-11-14
2023-06-30	$74,212,140	2,347,000	+33.5%	Shares	Sole	2023-08-14
2023-03-31	$54,157,170	1,757,779	+99.3%	Shares	Sole	2023-05-15
2022-12-31	$27,327,488	882,101	—	Shares	Sole	2023-02-14
No 13F history on record for this holder in this stock.